FRED Bi-Monthly Development Call

All,

This is a recurring invite to set times for the next few months for the FRED dev/project calls.

They will be every other Wednesday starting May 9 @ PST-7:00, EDT-10:00, UTC-14:00, CET-15:00, SAST-16:00.

The numbers to call are :

US Toll-Free 1800-220-9875

Canada Toll-free 1800-221-8656

S.A. Toll-free 0800-982-555

International(Not Toll-free) 1302-709-8332

PIN for ALL numbers #78889517

Agenda will be sent with a reminder the day before the call.

Please let me know if you have any questions.

Lorinne Banister PMP

Technical Project Manager HI-PPP

Regenstrief Institute

317.423.5669 (w)|317.501.5025 ©

lbanister@regenstrief.org

Confidentiality Notice: The contents of this message and any files transmitted with it may contain confidential and/or privileged information and are intended solely for the use of the named addressee(s).
Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state laws. Federal regulations and State laws prohibit you from making further disclosure of such information without
the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization for the release of medical or other information is not sufficient for this purpose. If you have received this
message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use of this information by anyone other than the intended recipient is strictly prohibited.

···

Hi FRED Team,

Looking forward to tomorrow’s facility registry call, please see the call info and agenda below. I don’t want to designate anyone on their behalf, but I included names where you might be a good person to start conversation on an item. Also below is the link to the country contact sheet for suggestions. Thanks much.

FRED
Bi-Monthly Development Call

Wednesday,
May 9th @ PST-7:00, EDT-10:00, UTC-14:00, CET-15:00, SAST-16:00.

US
Toll-Free 1800-220-9875

Canada
Toll-free 1800-221-8656

S.A.
Toll-free 0800-982-555

International(Not
Toll-free) 1302-709-8332

PIN for ALL numbers #78889517

Call Agenda

FRED funding status

Technical Discussion (Ed Jezierski and
Matt Berg)

Country outreach (key contacts, their
roles, state of readiness for participation)

a.
Tanzania (Ed Jezierski, Paul Biondich,
Sherri Fuller)

b.
Kenya (Paul Biondich, Andrew Ingles, Bob
Jolliffe)

c. Other candidate countries

See/revise
country contact sheet at https://docs.google.com/spreadsheet/ccc?key=0AoYTP_NBEUrfdHpCZTlCb0h1ZUd1RVl3aDA5Q0NGNmc

Rwanda FRED workshop – tentatively week of
June 25th

Best,

Kelly

keisling.kelly@gmail.com

···

On Fri, May 4, 2012 at 4:44 PM, Lorinne Banister lbanister@regenstrief.org wrote:

All,

This is a recurring invite to set times for the next few months for the FRED dev/project calls.

They will be every other Wednesday starting May 9 @ PST-7:00, EDT-10:00, UTC-14:00, CET-15:00, SAST-16:00.

The numbers to call are :

US Toll-Free 1800-220-9875

Canada Toll-free 1800-221-8656

S.A. Toll-free 0800-982-555

International(Not Toll-free) 1302-709-8332

PIN for ALL numbers #78889517

Agenda will be sent with a reminder the day before the call.

Please let me know if you have any questions.

Lorinne Banister PMP

Technical Project Manager HI-PPP

Regenstrief Institute

317.423.5669 (w)|317.501.5025 ©

lbanister@regenstrief.org

Confidentiality Notice: The contents of this message and any files transmitted with it may contain confidential and/or privileged information and are intended solely for the use of the named addressee(s).
Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state laws. Federal regulations and State laws prohibit you from making further disclosure of such information without
the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization for the release of medical or other information is not sufficient for this purpose. If you have received this
message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use of this information by anyone other than the intended recipient is strictly prohibited.